The role of AMPKα in high-glucose-induced dysfunction of cultured rat mesangial cells

Renal Failure

Volumn 34, Issue 5, 2012, Pages 616-621

  Lv, Zhi Mei ^a   Liu, Yi ^a   Zhang, Peng Ju ^a   Xu, Jing ^a   Jia, Zhen Hua ^a   Wang, Rong ^a   Wan, Qiang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

AMP activated protein kinase; Diabetic nephropathy; Hyperglycemia; Mesangial cells; Proliferation

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ACETYL COENZYME A CARBOXYLASE; COLLAGEN TYPE 4; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME PHOSPHORYLATION; GLUCOSE INTAKE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DIABETIC NEPHROPATHIES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLOMERULAR MESANGIUM; GLUCOSE; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SWEETENING AGENTS;

EID: 84860783463     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.668491     Document Type: Article

References (24)

1. Hovind P, Tarnow L, Rossing K, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care. 2003;26:1258-1264. (Pubitemid 36929282)
2. Bloomgarden ZT. Diabetic nephropathy. Diabetes Care. 2005;28:745-751. (Pubitemid 40315343)
3. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861-869.
4. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851-860.
5. The Diabetes Control and Complications Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int. 1995;47:1703-1720.
6. Schena FP, Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol. 2005;16:S30-S33. (Pubitemid 41725079)
7. Eddy AA. Progression in chronic kidney disease. Adv Chronic Kidney Dis. 2005;12:353-365. (Pubitemid 41376493)
8. Schnaper HW, Hayashida T, Hubchak SC, Pobcelet AC. TGFbeta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol. 2003;284:F243-F252. (Pubitemid 36114687)
9. Rutter GA, Silva Xavier DA, Leclerc I. Roles of 5-AMPactivated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J. 2003;375:1-16. (Pubitemid 37255376)
10. Myung-Ja L, Denis F, Meenalakshmi MM, et al. A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol. 2007;292:F617-F627.
11. Hiroyuki M, Barry JG, Motoyuki I, Eiichi A. AMPK and cell proliferation-AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol. 2006;574:63-71.
12. Hardie DG. The AMP-activated protein kinase pathway-New players upstream and downstream. J Cell Sci. 2004;117:5479-5487. (Pubitemid 40012195)
13. Park SH, Gammon SR, Knippers JD, et al. Phosphorylationactivity relationships of AMPK and acetyl-CoA carboxylase in muscle. J Appl Physiol. 2002;92:2475-2482. (Pubitemid 34666373)
14. Liu Y, Wan Q, Guan QB, Gao L, Zhao JJ. High-fat diet feeding impairs both the expression and activity of AMPKa in rats' skeletal muscle. Biochem Biophys Res Commun. 2006;339:701-707. (Pubitemid 41739724)
15. Bieke FS, De Vriese AS, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: The role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocrinol Rev. 2004;25:971-1010. (Pubitemid 39657775)
16. Myung JL, Denis F, Mariappan M, et al. A role for AMPactivated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol. 2007;292:F617-F627. (Pubitemid 46220529)
17. Philippe GC, Irene L, Gingras D, Bendayan M. Control of glycogen synthase through ADIPOR1-AMPK pathway in renal distal tubules of normal and diabetic rats. Am J Physiol Renal Physiol. 2008;294:F881-F889.
18. Wyatt M, Zanescu DI, Sood V, Beale EG, Prabhakar SS. The role of 5'-AMP-activated protein kinase (AMPK) in diabetic nephropathy: A new direction? Curr Enzyme Inhib. 2009;5:44-50.
19. Eduardo RR, José RP, Maria Fernanda AF, et al. A central role for neuronal AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in high-protein diet- induced weight loss. Diabetes. 2008;57:594-605.
20. Feng L, Gao L, Guan QB, et al. Long-term moderate ethanol consumption restores insulin sensitivity in high-fat-fed rats by increasing GLUT4 in the adipose tissue by AMPK activation. J Endocrinol. 2008;199:95-104.
21. Salt IP, Johnson G, Ashcroft SJ, Hardie DG. AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. Biochem J. 1998;335:533-539. (Pubitemid 28515405)
22. Cammisotto PG, Bendayan M. Adiponectin stimulates phosphorylation of AMP-activated protein kinase alpha in renal glomeruli. J Mol Histol. 2008;39:579-584.
23. Yi L, Lei J, Zun CL, et al. Emodin ameliorates high-glucose induced mesangial p38 over-activation and hypocontractility via activation of PPARγ. Exp Mol Med. 2009;41:648-655.
24. Wang R, Wan Q, Zhang Y, et al. Emodin suppresses interleukin- 1beta induced mesangial cells proliferation and extracellular matrix production via inhibiting p38 MAPK. Life Sci. 2007;80:2481-2488. (Pubitemid 46818295)